B12 and Blood Pressure: What Is the Connection?

Vitamin B12 influences blood pressure through several indirect pathways rather than acting as a direct blood-pressure-lowering nutrient. The most studied connection runs through homocysteine, an amino acid that B12 helps clear from the bloodstream. When B12 is low, homocysteine builds up and damages blood vessel walls, contributing to stiffer arteries and higher blood pressure over time. But the relationship has a surprising flip side: severe B12 deficiency can also cause blood pressure to drop dangerously low by damaging the nerves that regulate circulation.

How B12 Affects Blood Vessels Through Homocysteine

Your body uses B12 as a helper molecule to convert homocysteine into methionine, a harmless amino acid. When B12 runs low, homocysteine accumulates, and that buildup does measurable harm to blood vessel walls. In diabetic patients, researchers found that homocysteine concentration was strongly and independently linked to arterial stiffness even after accounting for age and other cardiovascular risk factors.¹ Stiffer arteries resist the stretch that normally absorbs each heartbeat’s surge of blood, which pushes systolic blood pressure upward.

The damage happens largely because homocysteine interferes with nitric oxide, the molecule that tells blood vessel walls to relax. Elevated homocysteine reduces nitric oxide production and availability, which clinically shows up as impaired ability of arteries to widen when blood flow increases.² Lab studies have confirmed this at the cellular level: homocysteine triggers accumulation of a substance called ADMA in endothelial cells, which directly blocks the enzyme responsible for making nitric oxide.³ The result is blood vessels that are less able to relax, contributing to higher resistance and elevated pressure.

This chain of events is not unique to B12 deficiency. Folate and vitamin B6 also help process homocysteine through different steps in the same pathway. That overlap is important because it means B12’s effect on blood pressure often cannot be cleanly separated from the effects of other B vitamins. A person whose homocysteine is high because of low folate will not see much benefit from B12 alone, and vice versa.

What Large Population Studies Reveal

Epidemiological research paints a fairly consistent picture: people who consume more B12 tend to have lower rates of high blood pressure. A national population-based study of U.S. adults found that higher dietary intake of B12 was linked to lower odds of hypertension in both men and women. Men in the highest intake group had roughly 16% lower odds of hypertension compared to those in the lowest group, and women showed a similar pattern at about 13% lower odds.⁴ The relationship followed a linear trend: as B12 intake went up, hypertension prevalence went down, though the benefits plateaued after the third-highest intake level, suggesting that more is not always better once adequate intake is reached.

That same study found even stronger associations for folate and vitamin B6, with reductions in hypertension odds closer to 35–40% when comparing the highest and lowest intake groups. This reinforces the idea that B12 is part of a team of nutrients influencing blood pressure, not a solo player. People who eat plenty of B12 also tend to have diets richer in folate and B6, which makes it difficult to attribute blood pressure benefits to any single vitamin from observational data alone.

Does Supplementing B12 Actually Lower Blood Pressure?

This is where the evidence gets frustratingly inconsistent. Observational studies suggest a connection, but controlled supplementation trials have not reliably shown that giving people B12 drops their blood pressure.

One trial gave vegetarians with low B12 status a course of B12 supplements. Their B12 levels rose and their homocysteine fell, exactly as expected. But their blood pressure did not budge in any meaningful direction.⁵ Systolic and diastolic readings were essentially the same after B12 as they were after placebo.

However, a study of vegans found a different result when B12 was combined with folic acid. That combination produced a significant drop in both systolic and diastolic blood pressure, along with a meaningful improvement in arterial stiffness.⁶ The improvement in arterial stiffness was substantial, and it tracked with the drop in homocysteine. The catch: because the treatment combined B12 and folate, it is impossible to know how much of the benefit came from B12 alone versus the combination.

Researchers who have reviewed the broader landscape of B-vitamin trials and blood pressure have noted that most studies find little or no blood pressure response to supplementation, even when homocysteine drops significantly.⁷ That disconnect between lower homocysteine and unchanged blood pressure has puzzled researchers for years. One possible explanation is that the vascular damage from chronically elevated homocysteine may already be done by the time supplementation begins. Another is that blood pressure is influenced by so many factors that nudging one pathway simply is not enough to move the needle in most people.

When B12 Deficiency Causes Blood Pressure to Drop

The homocysteine story is about blood pressure going up. But B12 deficiency can also make blood pressure fall too low, through an entirely separate mechanism involving the nervous system.

B12 is essential for maintaining the myelin sheath that insulates nerve fibers. When deficiency persists, nerve damage can extend to the autonomic nervous system, the network that controls involuntary functions like heart rate and blood vessel tone. Research comparing B12-deficient patients to healthy controls found that deficiency caused a pattern of autonomic dysfunction remarkably similar to what is seen in diabetic autonomic neuropathy, with impaired ability to activate the sympathetic nervous system and regulate blood pressure reflexes during position changes.⁸ In plain terms, when these patients stood up, their bodies could not properly tighten blood vessels to keep blood flowing to the brain, leading to a sudden drop in pressure.

This condition, called orthostatic hypotension, can cause dizziness, lightheadedness, and fainting. A published case report described a 90-year-old woman whose recurring episodes of near-fainting turned out to be caused by B12 deficiency that was just barely below normal. Her symptoms resolved completely with B12 replacement therapy.⁹ Cases like this tend to be underrecognized because doctors may not think of a vitamin deficiency when evaluating blood pressure problems, particularly in older adults who are already at risk for falls.

Severe B12 deficiency can also cause megaloblastic anemia, where red blood cells are abnormally large and ineffective at carrying oxygen. In extreme cases this leads to dangerously low blood pressure. One case involved an elderly patient hospitalized for hypotension and confusion whose condition rapidly improved after B12 treatment.¹⁰ The severe anemia itself reduced the blood’s ability to deliver oxygen, and the body’s compensatory mechanisms were not enough to maintain adequate pressure.

So B12 deficiency can pull blood pressure in either direction depending on the severity and which systems are affected. Mild, chronic deficiency tends to elevate homocysteine and promote arterial stiffness, nudging pressure upward. Severe deficiency damages nerves and red blood cells, potentially crashing pressure downward. The two scenarios can even overlap in the same patient.

Methylmalonic Acid and Hidden B12 Deficiency

Standard blood tests for B12 sometimes miss functional deficiency, where levels look normal but the body is not using B12 effectively. Methylmalonic acid, or MMA, is a metabolite that builds up when B12 is not doing its job properly inside cells, making it a more sensitive indicator of true B12 status.

Recent research has linked elevated MMA to cardiovascular problems, including hypertension. A study analyzing U.S. population data found that higher MMA was independently associated with the presence of cardiovascular diseases even after adjusting for B12 levels themselves, age, smoking, kidney function, and other standard risk factors. The association was strong: each unit increase in MMA roughly tripled the odds of having cardiovascular disease.¹¹

In older adults specifically, elevated MMA has been independently associated with hypertension. Researchers have proposed that MMA could serve as a screening tool alongside conventional risk assessments for identifying elderly individuals at higher risk of developing high blood pressure.¹² The thinking is that MMA captures something about metabolic stress and mitochondrial function that standard B12 measurements miss. For people whose B12 levels appear adequate on paper but whose cardiovascular risk seems higher than expected, MMA testing may reveal an underlying metabolic problem that conventional tests overlook.

Pregnancy, B12, and Blood Pressure Complications

The B12-blood pressure connection takes on particular urgency during pregnancy, when blood pressure disorders carry serious risks for both mother and baby. Preeclampsia, a dangerous condition marked by high blood pressure and organ damage during pregnancy, has been linked to lower B12 levels. A systematic review and meta-analysis found that women who developed preeclampsia had significantly lower B12 levels than healthy pregnant women.¹³ The difference averaged about 15 pg/mL lower in the preeclampsia group, though the studies varied considerably in their findings.

Whether low B12 actually contributes to causing preeclampsia or is merely a marker of other nutritional problems remains unclear. The elevated homocysteine that follows from low B12 could plausibly damage the placental blood vessels and contribute to the vascular dysfunction that defines preeclampsia, but the same women who are low in B12 often have inadequate folate and other nutrients as well. Still, the association is strong enough that some researchers consider B12 status worth monitoring during prenatal care, particularly in women who follow plant-based diets or have absorption problems.

There may also be consequences for the child. A study following mothers and their offspring found that lower maternal B12 concentrations during early pregnancy were associated with higher heart rates in children at ages five and six.¹⁴ While elevated heart rate is not the same as high blood pressure, it is an early marker of cardiovascular stress and suggests that maternal B12 status during pregnancy may have lasting effects on the cardiovascular programming of offspring.

Why Genetics Complicate the Picture

A genetic variant called MTHFR C677T, carried by a substantial fraction of the population, fundamentally changes how B vitamins interact with blood pressure. The MTHFR enzyme is a critical player in the same folate cycle where B12 operates. People who carry two copies of the variant (the TT genotype) produce a less efficient version of this enzyme, which tends to raise their homocysteine levels even when their B vitamin intake is adequate.

This variant has been shown to be independently associated with blood pressure itself, not just with homocysteine levels.⁷ Most B-vitamin supplementation trials have not accounted for participants’ MTHFR status, which may partly explain why average results across all participants are underwhelming. If the blood pressure benefit of B12 and folate supplementation is concentrated among the subset of people with the TT genotype, diluting those results across a mixed population would mask the effect. Riboflavin (vitamin B2) has been identified as a particularly potent modulator of blood pressure specifically in TT individuals, adding yet another B vitamin to the mix. This genetic dimension suggests that a one-size-fits-all approach to studying B vitamins and blood pressure may have been the wrong strategy all along.

Hydroxocobalamin in Critical Care

A specialized form of B12 called hydroxocobalamin has been investigated for an entirely different blood-pressure application: rescuing patients in vasodilatory shock, a life-threatening condition where blood vessels lose their ability to constrict and blood pressure plummets. The hypothesis was that hydroxocobalamin might scavenge nitric oxide (the same molecule discussed earlier) and restore vascular tone.

The largest case series on this question, analyzing nearly 4,000 hemodynamic measurements from 35 critically ill patients, found no meaningful effect. Mean arterial pressure showed essentially zero change in the 24 hours following hydroxocobalamin administration, and systolic, diastolic, and vasopressor requirements were similarly unaffected.¹⁵ This result was disappointing for intensive care physicians hoping for another tool in managing shock, but it underscores an important point: B12’s influence on blood pressure operates through slow, metabolic pathways rather than rapid pharmacological effects. You cannot meaningfully change blood pressure by giving someone a large dose of B12 in the short term.

Practical Implications for People Concerned About Blood Pressure

If you are managing high blood pressure or trying to prevent it, B12 status is worth knowing but is unlikely to be the main lever you pull. Getting enough B12 supports the metabolic machinery that keeps homocysteine in check and maintains healthy blood vessel function, but the blood pressure effect of correcting a B12 shortfall is modest at best in most people. The groups most likely to see meaningful cardiovascular benefit from addressing B12 include strict vegans and vegetarians (who get almost no B12 from food), older adults with absorption problems, people on long-term acid-reducing medications or metformin, and individuals with the MTHFR TT genotype who are already genetically predisposed to high homocysteine.

For those in these higher-risk groups, monitoring B12 status and, if warranted, MMA levels gives a more complete picture of metabolic health than either measurement alone. Supplementation is cheap and low-risk, but expecting B12 alone to meaningfully reduce blood pressure would be setting yourself up for disappointment. The evidence consistently suggests that B12 works best as part of a broader nutritional strategy that includes adequate folate and B6, alongside the lifestyle factors that have far larger effects on blood pressure: physical activity, sodium intake, body weight, and stress management.

If you experience unexplained dizziness or lightheadedness when standing, particularly if you are older or follow a plant-based diet, it is worth mentioning to your doctor that B12 deficiency can cause orthostatic hypotension. This is an underappreciated diagnosis that is straightforward to treat once identified. The autonomic nerve damage from B12 deficiency can be reversible if caught early, but prolonged deficiency may cause permanent changes.